ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

24,738Medicare Part D Prescriptions Filled, Including Refills

Rank: 19 out of 680

$1.81M Total Retail Price of All Prescriptions

Rank: 10 out of 680

665 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
73% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 665 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

15% of this provider’s 665 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 21,083 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$73 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
LEVOTHYROXINE SODIUM 829 720 1 2
AMLODIPINE BESYLATE 567 510 2 1
NAMENDA 483 460 3 35
WARFARIN SODIUM 475 394 4 20
LISINOPRIL 474 402 5 5
DONEPEZIL HCL 462 449 6 27
OMEPRAZOLE 436 360 7 7
FUROSEMIDE 377 340 8 6
GABAPENTIN 370 267 9 15
METOPROLOL TARTRATE 342 308 10 12
METFORMIN HCL 341 271 11 8
SIMVASTATIN 312 272 12 3
KLOR-CON M20 310 298 13 61
ATORVASTATIN CALCIUM 284 273 14 11
HYDROCODONE-ACETAMINOPHEN 281 159 S3 15 4
RANITIDINE HCL 275 272 16 56
PANTOPRAZOLE SODIUM 261 228 17 30
ESCITALOPRAM OXALATE 260 245 18 45
RISPERIDONE 253 225 19 80
CARVEDILOL 248 216 20 23
QUETIAPINE FUMARATE 247 218 21 64
EXELON 234 234 22 112
POTASSIUM CHLORIDE 233 218 23 14
PRAVASTATIN SODIUM 215 197 24 10
JANTOVEN 212 134 25 147
POLYETHYLENE GLYCOL 3350 201 181 26 62
LANTUS 200 174 27 49
DIOVAN 199 170 28 31
TRAMADOL HCL 197 161 29 18
METOPROLOL SUCCINATE 191 177 30 13
LEVOFLOXACIN 186 156 31 97
VENLAFAXINE HCL ER 185 142 32 101
CRESTOR 178 140 33 25
CLOPIDOGREL 177 162 34 26
CITALOPRAM HBR 177 140 34 22
BYSTOLIC 175 137 36 79
ALENDRONATE SODIUM 173 169 37 32
ZOLPIDEM TARTRATE 173 106 37 17
BUMETANIDE 170 154 39 102
HYDROCHLOROTHIAZIDE 170 146 39 9
ADVAIR DISKUS 165 138 41 53
CYMBALTA 161 118 42 46
MEGESTROL ACETATE 160 160 R 43 88
MELOXICAM 156 133 44 24
ATENOLOL 154 125 45 19
FLUTICASONE PROPIONATE 153 125 46 41
PREDNISONE 151 136 47 50
TAMSULOSIN HCL 146 132 48 34
DOXYCYCLINE HYCLATE 146 119 48 95
NEXIUM 146 113 48 16
AMITRIPTYLINE HCL 140 107 R 51 47
TRAZODONE HCL 134 99 52 48
RAMIPRIL 132 126 53 69
CEFUROXIME 132 119 53 179
NOVOLOG 130 110 55 167
PLAVIX 128 114 56 39
MIRTAZAPINE 126 99 57 78
FLUOXETINE HCL 126 89 57 74
NYSTATIN 126 114 57 191
DIGOXIN 125 106 60 58
DIVALPROEX SODIUM 124 121 61 110
JANUVIA 123 110 62 60
CIPROFLOXACIN HCL 122 105 63 57
ISOSORBIDE MONONITRATE ER 119 118 64 59
LACTULOSE 117 79 65 92
SEROQUEL 113 103 66 123
NOVOLOG FLEXPEN 106 93 67 189
DILTIAZEM 24HR ER 105 102 68 132
VESICARE 104 90 69 176
NIASPAN 101 92 70 181
ENALAPRIL MALEATE 100 89 71 65
KLOR-CON M10 100 100 71 127
FENTANYL 99 83 S2 73 183
ENABLEX 98 85 74 217
LOSARTAN POTASSIUM 96 88 75 21
OXYBUTYNIN CHLORIDE ER 95 86 76 143
SERTRALINE HCL 94 80 77 28
ALBUTEROL SULFATE 93 86 78 154
CARBIDOPA-LEVODOPA 90 82 79 117
CLONIDINE HCL 90 84 79 36
SPIRONOLACTONE 89 83 81 82
NAPROXEN 88 77 82 121
LOVASTATIN 84 75 83 44
LEVEMIR FLEXPEN 84 81 83 186
NITROFURANTOIN 81 63 85 269
TRICOR 81 72 85 98
BUSPIRONE HCL 78 63 87 144
OXYBUTYNIN CHLORIDE 78 69 87 129
TRIAMCINOLONE ACETONIDE 78 77 87 199
LIPITOR 76 74 90 68
ALLOPURINOL 76 59 90 33
AVODART 74 62 92 218
HUMALOG 73 66 93 196
SPIRIVA 71 66 94 70
LEXAPRO 71 68 94 128
AZITHROMYCIN 70 57 96 42
LYRICA 70 44 96 77
AMOXICILLIN 68 55 98 111
BENZTROPINE MESYLATE 67 55 R 99 137
SYNTHROID 67 62 99 38
GLIMEPIRIDE 67 52 99 29
FLUCONAZOLE 66 47 102 139
ROPINIROLE HCL 65 49 103 99
LIOTHYRONINE SODIUM 65 59 103 324
NYSTOP 64 62 105 305
LANTUS SOLOSTAR 63 32 106 84
ENOXAPARIN SODIUM 63 49 106 260
NASONEX 62 53 108 197
LATANOPROST 62 62 108 209
TIZANIDINE HCL 61 36 110 140
SINGULAIR 60 51 111 91
GLIPIZIDE 59 56 112 63
DIVALPROEX SODIUM ER 59 26 112 148
METOLAZONE 59 57 112 201
CYCLOBENZAPRINE HCL 58 40 R 115 81
DILTIAZEM HCL 58 47 115 291
AMOX TR-POTASSIUM CLAVULANATE 57 47 117 124
AMLODIPINE BESYLATE-BENAZEPRIL 56 53 118 43
PROAIR HFA 54 46 119 67
METHYLDOPA 54 45 R 119 446
CYPROHEPTADINE HCL 53 48 R 121 297
PAROXETINE HCL 53 50 121 76
MUPIROCIN 53 48 121 130
PEN NEEDLE 52 36 124 122
SULFAMETHOXAZOLE-TRIMETHOPRIM 52 31 124 94
TRILIPIX 52 43 124 264
NITROFURANTOIN MONO-MACRO 51 44 127 172
PRAMIPEXOLE DIHYDROCHLORIDE 51 34 127 204
TERAZOSIN HCL 51 46 127 180
OLANZAPINE 50 47 130 116
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 16, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.